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TConclusion: Transfemoral commercial use of the Edwards SAPIEN valve for
inoperable patients shows similar in-hospital mortality and stroke rates compared to
PARTNER Cohort B. The reﬁnements in the procedure, such as more conscious
sedation, experience of the operators and careful vascular planning in the com-
mercial group led to lower vascular and bleeding complications and shorter length
of stay.CRT-709
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Background: Trans-apical (TA) access is an alternative to the more common trans-
femoral (TF) access for Transcatheter Aortic Valve Replacement (TAVR). The impact
of the access site on outcome is not clearly established.
Methods: All patients undergoing TAVR (n¼446) by accessing through either TA
(n¼108; 24.2%) or TF (n¼338; 75.8%) were included for the comparison of baseline
characteristics, procedural data and outcome.Results: TA patients were older (84.905.22 vs. 83.058.04 years; p<0.05), had
higher incidence of peripheral vascular disease (57.3% vs. 31.6%; p<0.001) and higher
Society of Thoracic Surgeons Score (11.134.52 vs. 9.504.47; p¼0.002). No dif-
ferences were noted in the stroke rate (TA-4.7% vs. 6.2%; p¼0.55). TF access was
associated with higher rates of major vascular complications (10.4% vs.3.7%; p¼0.03)
but the rate of life threatening bleeding and post-procedural acute kidney injury were
higher in the TA group (14.0% vs. 5.0%; p¼0.002 & 3.1% vs.0.3%; p¼0.04,
respectively). These disparities translated into longer hospital stay (TA-11.819.97 vs.
TF-8.546.11 days; p¼0.002), higher rates of 30-days and 1 year mortality rates in
the TA patients (18.5% vs.5.6%; p<0.001, 30.6% vs. 18.9%; p¼0.01). A landmark
analysis (ﬁgure) demonstrated that beyond 30 days, no difference were noted in the
mortality (log rank for 30d<0.001; for 1 year p¼0.93).
Conclusion: TA is an alternative for TF-TAVR and was reserved for patients with
higher rate of co-morbidities and contraindicated to TF. TA access was further
associated with higher rates of post-procedural morbidity and mortality mainly in the
ﬁrst month after the procedure. The further development of smaller caliber sheaths will
hopefully mitigate the use of TA or other alternative access sites.CRT-710
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Background: Balloon aortic valvuloplasty (BAV) is being used more and more as a
bridging procedure to more deﬁnitive surgery or TAVR. The present study aims at
evaluating the gender differences in clinical characteristics and outcomes of patients
undergoing BAV in TAVR era.
Methods: From April 2009 to August 2012, the data from 331 BAV procedures done
on patients with severe symptomatic AS were prospectively entered into a dedicated
database. Clinical, hemodynamic, procedure and outcome data were collected. All
events were deﬁned according to Valve Academic Research Consortium [VARC]
criteria.
Results: The study cohort included 331 patients with mean age 82.510.2 years and
mean aortic valve area 0.610.20. Men constitute 46% of the study population. Prior
history of coronary artery disease (CAD), prior CABG, and lower EF [25-40%] were
higher in men compared to women at presentation. On the other hand women had
higher Society of Thoracic Surgeons (STS) score (p¼0.006). There were no signiﬁcant
differences in the procedural characteristics except for signiﬁcantly smaller balloon size
(p<0.001) in women compared to men. Procedure complications similar both groups
(overall 7%). All cause mortality 30 day and 1 year [28.5% vs. 34.2%, p¼0.3] similar in
both groups.
Conclusion: Women have higher STS score and men have higher CAD burden at
presentation though the procedure outcomes, in hospital complications and one year
all cause mortality after BAV have been similar.
